STAGE IV NON-HODGKIN LYMPHOMA

Clinical trials for STAGE IV NON-HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new STAGE IV NON-HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for STAGE IV NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested to fight tough blood cancers

Disease control Ongoing

This study is testing if adding a new drug called selinexor to the standard chemotherapy regimen (RCHOP) is safe and more effective for treating B-cell non-Hodgkin's lymphoma. It will first find the safest dose of the combination, then see how well it works for newly diagnosed pa…

Matched conditions: STAGE IV NON-HODGKIN LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

STAGE IV NON-HODGKIN LYMPHOMA

Get alerted when new STAGE IV NON-HODGKIN LYMPHOMA trials appear

New drug combo tested to fight tough blood cancers